American Century Companies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1M Buy
64,919
+12,249
+23% +$4.54M 0.01% 1183
2026
Q1
$15.4M Sell
52,670
-45,638
-46% -$15M 0.01% 1290
2025
Q4
$34.5M Sell
98,308
-6,638
-6% -$2.24M 0.02% 896
2025
Q3
$33.9M Buy
104,946
+7,016
+7% +$2.18M 0.02% 878
2025
Q2
$38.1M Buy
97,930
+10,486
+12% +$4.22M 0.02% 792
2025
Q1
$38M Buy
87,444
+2,605
+3% +$1.05M 0.02% 736
2024
Q4
$31.3M Sell
84,839
-32,222
-28% -$13.5M 0.02% 841
2024
Q3
$60.9M Buy
117,061
+13,849
+13% +$7.4M 0.04% 521
2024
Q2
$55.9M Buy
103,212
+9,442
+10% +$4.99M 0.03% 528
2024
Q1
$48.6M Sell
93,770
-6,832
-7% -$3.4M 0.03% 566
2023
Q4
$47.4M Sell
100,602
-8,141
-7% -$3.76M 0.03% 521
2023
Q3
$47.3M Buy
108,743
+6,434
+6% +$2.92M 0.04% 474
2023
Q2
$45.5M Buy
102,309
+14,965
+17% +$6.9M 0.03% 476
2023
Q1
$40M Sell
87,344
-590
-0.7% -$281K 0.03% 499
2022
Q4
$45.1M Sell
87,934
-38,556
-30% -$19.6M 0.04% 441
2022
Q3
$57.5M Buy
126,490
+6,754
+6% +$3.23M 0.05% 362
2022
Q2
$57.8M Sell
119,736
-24,970
-17% -$12.4M 0.05% 389
2022
Q1
$71.1M Sell
144,706
-6,075
-4% -$2.78M 0.05% 367
2021
Q4
$69.9M Buy
150,781
+23,006
+18% +$9.68M 0.04% 408
2021
Q3
$47.6M Buy
127,775
+113,425
+790% +$43.1M 0.03% 464
2021
Q2
$5.48M Sell
14,350
-205,039
-93% -$78.4M ﹤0.01% 968
2021
Q1
$78.8M Buy
219,389
+86,691
+65% +$27.9M 0.06% 344
2020
Q4
$42.6M Sell
132,698
-46,178
-26% -$14.2M 0.03% 431
2020
Q3
$48M Buy
178,876
+170,879
+2,137% +$46M 0.04% 357
2020
Q2
$2.1M Buy
7,997
+1,625
+26% +$434K ﹤0.01% 899
2020
Q1
$1.45M Buy
6,372
+825
+15% +$225K ﹤0.01% 918
2019
Q4
$1.68M Buy
5,547
+1,061
+24% +$292K ﹤0.01% 976
2019
Q3
$1.08M Buy
4,486
+382
+9% +$105K ﹤0.01% 1019
2019
Q2
$1.16M Buy
4,104
+199
+5% +$54.4K ﹤0.01% 1075
2019
Q1
$1.12M Sell
3,905
-230
-6% -$66.5K ﹤0.01% 1049
2018
Q4
$1.09M Sell
4,135
-676
-14% -$186K ﹤0.01% 1048
2018
Q3
$1.32M Buy
4,811
+41
+0.9% +$10.6K ﹤0.01% 1076
2018
Q2
$1.14M Sell
4,770
-7,826
-62% -$1.81M ﹤0.01% 1089
2018
Q1
$2.77M Buy
12,596
+287
+2% +$67.4K ﹤0.01% 947
2017
Q4
$2.77M Sell
12,309
-33,855
-73% -$7.21M ﹤0.01% 958
2017
Q3
$8.77M Sell
46,164
-477,778
-91% -$90.9M 0.01% 690
2017
Q2
$98.6M Buy
523,942
+48,258
+10% +$8.67M 0.1% 253
2017
Q1
$78.7M Buy
475,684
+251,663
+112% +$40M 0.08% 300
2016
Q4
$32.2M Sell
224,021
-81,795
-27% -$11M 0.03% 445
2016
Q3
$38.3M Buy
305,816
+68,740
+29% +$8.88M 0.04% 410
2016
Q2
$31.1M Buy
237,076
+16,780
+8% +$2.3M 0.04% 447
2016
Q1
$30.6M Sell
220,296
-54,548
-20% -$7.29M 0.04% 442
2015
Q4
$38.3M Sell
274,844
-40,767
-13% -$5.62M 0.04% 413
2015
Q3
$44.2M Buy
315,611
+63,383
+25% +$9.53M 0.05% 392
2015
Q2
$41.4M Sell
252,228
-28,295
-10% -$4.52M 0.05% 424
2015
Q1
$43.3M Sell
280,523
-50,640
-15% -$7.21M 0.05% 414
2014
Q4
$41.6M Buy
331,163
+104,146
+46% +$12.9M 0.05% 423
2014
Q3
$27.2M Sell
227,017
-67,037
-23% -$7.69M 0.03% 472
2014
Q2
$31.6M Sell
294,054
-62,445
-18% -$6.43M 0.04% 454
2014
Q1
$35.5M Sell
356,499
-92,797
-21% -$8.39M 0.04% 431
2013
Q4
$41.5M Sell
449,296
-9,583
-2% -$851K 0.05% 392
2013
Q3
$38.4M Buy
458,879
+37,040
+9% +$3.17M 0.05% 393
2013
Q2
$34.5M Buy
+421,839
New +$31.6M 0.05% 411

Other funds holding ELV

American Century Companies's ELV Position: Q2 2026 in Review

American Century Companies increased its Elevance Health (ELV) stake by 23% in Q2 2026, buying an estimated $4.54M and bringing the position to 64,919 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #1183.

American Century Companies first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $98.6M in Q2 2017. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • American Century Companies held 64,919 shares of Elevance Health worth $25.1M as of Q2 2026.
  • American Century Companies bought 12,249 Elevance Health shares in Q2 2026, an estimated $4.54M.
  • Elevance Health made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1183 holding.
  • American Century Companies first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • American Century Companies's Elevance Health position peaked at $98.6M in Q2 2017.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.